Camber gets FDA nod for generic BentylGeneric Bentyl is Camber's first injectable product to hit the market. FDA approves third indication for Lupin’s generic LevoxylLupin's levothyroxine sodium tablets now is approved as a generic of Synthroid, Unithroid, and Levoxyl. Alembic launches generic Tricor Alembic is launching generic Tricor tablets in two dosage strengths. SunGen gets FDA nod for lidocaine ointment Lidocaine has a market value of about $60 million. Aurobindo’s generic Lodosyn gets FDA OK Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA. Lupin gets FDA nod for generic Depakote Divalproex sodium ER tablets, 250 mg and 500 mg had a market value of roughly $159 million, according to IQVIA June 2019 data. Alembic’s Aleor joint venture gets FDA green light for generic desonide Desonide ointment, 0.05%, had a market value of $13 million for the 12 months ended December 2018, according to IQVIA. Sun Pharmaceuticals introduces pantoprazole injection Sun Pharmaceuticals' pantoprazole injection is intended to support a product shortage. Liva gets FDA nod for generic Haldol Liva has received the Food and Drug Administration's approval for generic Haldol, which is indicated for schizophrenia and Tourette syndrome. FDA generic approvals reached a record high in fiscal year 2019 In fiscal year 2019, the FDA approved a total of 1,171 generic drug approvals, which comprised 935 full approvals and 236 tentative approvals. First Previous 173 174 175 176 177 Next Last
